Cost Analysis of Ganciclovir and Foscarnet in Recipients of Allogeneic Hematopoietic Cell Transplant with Cytomegalovirus Viremia

BACKGROUND: Ganciclovir (GCV) and foscarnet (FOS) are the most commonly used antivirals for preemptive treatment of cytomegalovirus (CMV) viremia in recipients of allogeneic hematopoietic cell transplantation (alloHCT). The current literature indicates similar efficacy between these agents. Thus, th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transpl Infect Dis
Main Authors: Chen, Jason, Ross, Justine Abella, Tegtmeier, Bernard, Yang, Dongyun, Ito, James I., Zaia, John A., Dickter, Jana K, Nakamura, Ryotaro, Mokhtari, Sally, Kriengkauykiat, Jane, Al Malki, Monzr M., Dadwal, Sanjeet S
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7162712/
https://ncbi.nlm.nih.gov/pubmed/31840347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados